ObjectiveAnal incontinence (AI) is a symptom associated with age, bowel symptoms and
obstetric injuries. Primary aim of the study was to establish the prevalence of AI
among women and secondarily to evaluate the impact on daily life and conditions
associated with AI.DesignA cross-sectional study.SettingParticipants attended research stations located in different parts of
Nord-Trøndelag county, Norway. Data were collected through interviews,
questionnaires and clinical examinations.ParticipantsIn total, 40 955 community-dwelling women aged 30 years and older
were invited. A total of 25 037 women participated, giving a participation
rate of 61.1%.Primary and secondary outcome measuresFecal incontinence and flatal incontinence was defined as involuntary loss of
feces and flatus weekly or more, respectively. AI was defined as the involuntary
loss of feces and/or flatus weekly or more. Urgency was defined as the inability
to defer defecation for 15 min. Statistical methods included prevalence
estimates and logistic regression analysis.ResultsQuestions about AI were completed by 20 391 (82.4%) women. Among the
20 391 women, AI was reported by 19.1% (95% CI 18.6% to 19.7%) and fecal
incontinence was reported by 3.0% (95% CI 2.8% to 3.2%). Urgency was experienced
by 2586 women (12.7%, 95% CI 12.2 to 13.1). Impact on daily life was stated by 794
(26.0%, 95% CI 24.4 to 27.5) women with AI. In bivariate age-adjusted analysis of
AI, OR and CI for urgency (OR 3.19, 95% CI 2.92 to 3.49) and diarrhoea (OR 3.81,
95% CI 3.32 to 4.38) revealed strongest associations with AI.ConclusionsAI affects one in five women older than 30 years. Strongest associated
symptoms are urgency and diarrhoea.Trial registration numberThe study was approved by the Regional Committee for Medical and Health Research
Ethics (No. 2009/1214) and followed the Declaration of Helsinki.
Procalcitonin (PCT). a new marker proposed as a diagnostic tool for bacterial infections, triggers a systemic-inflammatory reaction in the body (sepsis, septic shock) and has potential use in a wide range of patient settings. To interpret the results from PCT measurements, we depend on reference intervals established from relevant populations. PCT and C-reactive protein (CRP) concentrations were analysed in 47 patients with a normal postoperative course after major abdominal surgery. The mean concentration of PCT declines from the first day and reaches half its initial values on the second day after the operation. whereas the mean concentration of CRP increases in the first 48 h and reaches half its maximum value on the fifth day after the operation. We present a continuous reference interval for plasma PCT and CRP concentrations in the first week following major abdominal surgery. For PCT we also present a graphic display of expected mean and expected upper reference limits predicted from the value measured on the first postoperative day.
More than half of patients operated with restorative proctocolectomy will need surgical intervention within 20 years and the failure rate is more than 10%. The high risk of complications and failure inherent in the procedure should not be ignored.
An association between primary sclerosing cholangitis and chronic/severe pouchitis was found, but not with other extraintestinal manifestations. Functional results were good and alike in patients with and without primary sclerosing cholangitis. Primary sclerosing cholangitis is a risk factor for chronic pouchitis and is associated with neoplasia.
SNM was superior to Permacol® in terms of reduction of St Mark's score, ICIQ-UI-SF and the change of the FIQL in women with faecal incontinence following OASIS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.